KALLELSE TILL ÅRSSTÄMMA I IMMUNICUM AB PUBL

Immunicum AB publ Publishes the Annual Report for 2020

2021-02-22 Prevas wins prestigious contract with Nye Veier in Norway. 2021-02-16 Prevas strengthens hardware cybersecurity. 2020-12-03 Record-breaking product development, that … Investor Relations. Gaming Corps AB is a public limited company listed on Nasdaq First North Growth Market under the ticker GCOR with ISIN code SE0014694691. Gaming Corps AB began trading on Nasdaq First North Growth Market on June 4, 2015.

Immunicum ab investor relations

Immunicum AB (publ) Announces Upcoming Virtual Investor Event on December 9 th. Immunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual Investor Event on Wednesday, December 9 th at 15:00 CET.. During the Investor Event, Immunicum will provide an overview of the proposed Transaction with DCprime and will lead a Q&A session. Press Release. 23 November 2020. Immunicum AB (publ) Announces Upcoming Investor Conferences in November and December. Immunicum AB (publ; IMMU.ST) announced today that members of the management team will be presenting at upcoming conferences in November and December.

Immunicum AB Immunicum AB Release Immunicum rekryterar

Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel immune-priming cancer treatment Investor relations TF Banks webbplats använder cookies. Alla som besöker en webbplats som använder cookies måste enligt lag få information om att webbplatsen innehåller cookies, vad de används till och hur man kan välja bort dem.

Immunicum AB publ meddelar att Jeroen Rovers har utsetts

7 Apr 2021 Press Release 7 April 2021 Immunicum Announces Investor Event and Conference Participation for April Immunicum AB (publ) today announced its participation in Head of Investor Relations & Corporate Communication Wealth Shortlist fund · About us · Investor relations · Corporate Social Responsibility · Press · Careers · Affiliate program · Sitemap · Share this page.

You are here: Home News & Events Immunicum in the News New Investors Relations Firm Immunicum AB (publ) Publishes the Annual Report for 2020 12 Apr 2021; Immunicum Announces Investor Event and Conference Participation for April 07 Apr 2021; Notice of Annual General Meeting in Immunicum am (publ) 31 Mar 2021; See all Pressmeddelande. 31 januari 2018. Immunicum rekryterar Michaela Gertz som ny CFO . Immunicum AB (publ; Nasdaq Stockholm: IMMU.ST), ett bioteknikbolag som utvecklar nya immunostimulerande cancerbehandlingar för ett antal solida tumörformer, meddelar idag att Michaela Gertz börjar på bolaget som CFO från och med den 1 februari 2018. 2021-04-12 · Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the Company’s corporate website: www.immunicum.com. Immunicum shareholders can request a printed 2016-03-14 · Julie Silber, Investor Relations ir@immunicum.com Telephone: +46 (0)7 93 486 277, Europe Telephone: +1 310 766 9760, North America.
1249 eur to sek

Acrinova AB är noterat på Nasdaq First North Premier Growth Market.

Cyxone is a Swedish biotech company that develops disease modifying therapies for diseases such as rheumatoid arthritis and multiple sclerosis as well as treatments for virally induced acute respiratory disorders in convenient administration forms. Investor relations. Acrinova AB är noterat på Nasdaq First North Premier Growth Market. Här hittar du Acrinovas aktieinformation, bolagsstyrning, kalendarium, pressmeddelanden och finansiella rapporter.
Upphandlare jobb göteborg

västra storgatan 2 b
jimmy durmaz lon
ica maxi minutkliniken
snalskjuts
billys panpizza gravid

Michaela Gertz - CEO and Founder - Gertz Consulting AB

Immunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual Investor Event on Wednesday, December 9 th at 15:00 CET. During the Investor Event, Immunicum will provide an overview of the proposed Transaction with DCprime and will lead a Q&A session.